Patent 8980874 was granted and assigned to Midwestern University on March, 2015 by the United States Patent and Trademark Office.
Methods of treating diabetic ketoacidosis are disclosed. The methods utilize an endothelin antagonist to treat diabetic ketoacidosis in mammals, including humans.